
Eyecelerator @ AAO 2026
Register to join us: Oct. 8 | New Orleans
CONFERENCE SPEAKERS

EyeBio, a Merck Company
Anthony P. Adamis
Co-Founder, Chief Scientific Officer

California Retina Consultants
Robert L. Avery, MD
Founder/CEO, Program Co-Chair

Barclays Biopharmaceutical Investment Banking
Jim Birchenough, MD
Chairman & Global Co-Head
Science Corporation
Frank Brodie, MD, MBA
Chief Medical Officer

Altos Eye Physicians
David F. Chang, MD
Ophthalmologist

Bascom Palmer Eye Institute
Kendall Donaldson, MD, MS
Professor of Clinical Ophthalmology

AbbVie
Doug Faunce
Executive Director

Rothschild Foundation
Damien Gatinel, MD, PhD
Head of Anterior Segment & Refractive Surgery

Wills Eye Hospital
Allen C. Ho, MD
Director of Retina Research, Retina Program Director

Marketscope
Kristen Harmon Ingenito
CEO

InterWest Partners​
Gil Kliman, MD
Managing Partner, Program Director

Bausch + Lomb
Cathleen McCabe, MD
Strategic Medical Advisor

Singapore National Eye Centre
Jod Mehta, MBBS, PhD, FRCOphth
Professor

RxSight
Aziz Mottiwala
President and Chief Executive Officer

Johnson & Johnson
Erin Powers
President, Surgical Vision, North America

Horizon Surgical Systems
Rajesh K. Rajpal, MD
Chief Strategy and Medical Officer

University of California
Julie M. Schallhorn, MD, MS
​Professor and Program Co-Chair

Stanford Medicine​
Kuldev Singh, MD, MPH
Professor of Ophthalmology and Program Co-Chair
​

Center for Devices and Radiological Health
Michelle Tarver, MD, PhD
Director

CBER
Katerina Tsilou, MD
Medical Officer & Clinical Reviewer

Alcon
Laurent Attias
SVP, Corporate Strategy, BD&L and M&A

Nanoscope Therapeutics
Samuel B. Barone, MD
Chief Medical Officer

FDA Ophthalmology Division
William M. Boyd, MD
Director

Ocular Advisors
Wiley Chambers, MD
Ophthalmic Pharmaceutical Consultant

Glaukos
Robert Davis
SVP & General Counsel

Ocular Therapeutix
Pravin U. Dugel, MD
President & CEO

Topcon Healthcare
Daniela Ferrara, MD, PhD
Chief Medical Officer

Visionary Ventures
Garrett Hamontree, MBA
Partner & CFO


Astellas Pharma
Erin Kimbrel, PhD
Head of Cell & Gene Therapy Research​

Patient Square Capital
Jim Mazzo
Senior Advisor

American Academy of Ophthalmology
Stephen D. McLeod, MD
CEO​, Program Committee

STAAR Surgical
Magda Michna, PhD
Chief Clinical, Regulatory & Medical Affairs Officer

Glaukos​​
Tomas Navratil, PhD
Chief Development Officer

Cleveland Clinic, Cole Eye Institute
Aleksandra Rachitskaya, MD
Associate Professor of Ophthalmology

Bausch + Lomb
Brent Saunders
CEO

Tarsus Pharmaceuticals
Sara Siddiqi
VP, Business Development & Corporate Strategy

Bausch + Lomb
Andrew Stewart
​President, Global Pharmaceuticals & International Consumer

Vance Thompson Vision
Vance Thompson, MD
Ophthalmologist
